REHAN IFTIKHAR
TUCSON, AZ. NPI 1861400749. Gastroenterology.
American Factbook Research
What was reported, 2019–2025
- $5.5 thousand
- General payments
- $5,461
- 285 separate payments. Meals, travel, speaking and consulting fees, gifts.
- $70.9 thousand
- Research payments
- $70,918
- Funding for a study, usually paid to an institution with this doctor named on it. Not added to general payments, and not income.
- $0
- Ownership and investment
- The value of a stake this doctor or an immediate family member held.
- 0
- Disputed
- This doctor has contested none of the payments reported about them.
By program year
2 more columns on a wider screen
| Program year | General | Research |
|---|---|---|
| 2025 | $793 | $0 |
| 2024 | $1,536 | $0 |
| 2023 | $1,463 | $3,892 |
| 2022 | $696 | $0 |
| 2021 | $155 | $0 |
| 2020 | $285 | $0 |
| 2019 | $533 | $67,026 |
CMS reports a program year at a time and also publishes its own total across them, which is what the figures above are. These rows are that total taken apart, not a second set of payments.
The record
- 1861400749
- National Provider Identifier
- The identifier this page is addressed by, and the one both CMS files share.
- Gastroenterology
- Specialty
- Allopathic & Osteopathic Physicians, in CMS's taxonomy.
- MO
- Licensed in
- The state of the licence CMS lists first.
- Covered Recipient Physician
- Recipient type
- How CMS classifies the recipient of these payments.
Medicare prescribing
What this provider billed to Medicare Part D in 2024, as CMS published it. Medicare Part D only: what they prescribed outside it is not here.
- 2,959
- Claims
- Prescriptions and refills billed to Part D, as CMS counts them.
- $508,806
- Total drug cost
- What Part D, the plan and the patient paid together. Not what this provider was paid — they are paid nothing out of it.
- 1,375
- Beneficiaries
- People with at least one prescription from this provider.
- Withheld
- Brand-name claims
- Of the claims above, those for a brand-name drug. CMS withheld this value and marked it "#". It publishes two markers and two reasons — a value between 1 and 10, or one withheld so another cannot be worked out — without saying which marker means which.
- 2,322
- Generic claims
- Of the claims above, those for a generic.
- not reported
- Opioid claims
- Claims for an opioid. CMS published no figure for this provider, and there is no suppression marker on this measure — so this is an absent figure rather than a withheld one, and it is not a zero.
- 68
- Antibiotic claims
- Claims for an antibiotic.
- Gastroenterology
- Prescriber type
- As CMS classifies this prescriber. Credentials: MD.
A blank is not a zero. CMS withholds a value between 1 and 10, and withholds the next lowest alongside it so the first cannot be worked out by subtraction — so a withheld figure is not even evidence that the number was small. Rows for ten or fewer claims are removed from the file altogether, which is why the parts of a total can be withheld while the total is published.
Elsewhere
- Payments to doctors in Arizona — what was reported across the state this doctor practises in.
- What drug and device companies pay doctors — the national picture these figures are part of.
- This record at CMS — the publisher’s own page for this profile.
- The NPI registry — who this identifier belongs to, at CMS.
Data retrieved
Sources
- Open Payments — payments grouped by physician — Centers for Medicare & Medicaid Services · U.S. Government work. CMS declares `https://www.usa.gov/government-works` as the licence on every one of its 74 Open Payments datasets, with `accessLevel: public`. That page states a government work is "something created by a U.S. government officer or employee as part of their official duties" and is generally not protected by copyright, subject to conditions that do bind us: "You cannot use government materials in a way that implies endorsement by a government agency, official, or employee", and "You also cannot use federal government trademarks or federal government agency logos without permission." · retrieved September 22, 2026